Madrigal pads MASH pipeline with six siRNAs from China's Ribo

Madrigal Pharmaceuticals is on a mission to become a generational, independent player in the MASH field with its third deal in eight months. The first FDA-approved medicine for the fatty liver disease, Rezdiffra, has now ...